4//SEC Filing
Degnan Chris 4
Accession 0000899243-23-006470
CIK 0001563577other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:57 PM ET
Size
5.3 KB
Accession
0000899243-23-006470
Insider Transaction Report
Form 4
Degnan Chris
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-25+185,000→ 185,000 totalExercise: $1.78Exp: 2033-02-24→ Common Stock (185,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 25, 2023.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001741968
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 6:57 PM ET
- Size
- 5.3 KB